Bryce Allen, MD
Orthopaedic Surgery · Temple, TXNPI 1518182831
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,871 of the $2,635 with a category attached, or 71.0%. Stryker accounts for 74.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,054 and has fallen 66.8% since, to $350 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in TX, where the typical reported total is $4,671.
Across 23 payments — averaging $114.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Zimmer Biomet$514
- Next Science LLC$130
- Si-bone, Inc.$21
Across 14 payments — averaging $4709.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$58K
- Janssen Research & Development, LLC$8K
What the payments were for
- Travel & lodging$76429%
- Food & beverage$1,87171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 16 | $1,969 |
| Zimmer Biomet | 5 | $514 |
| Next Science LLC | 1 | $130 |
| Si-bone, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,635 in reported general payments places this provider in the 35th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 230 | $1,592 |
| Mupirocin | 145 | $916 |
| Celecoxib | 61 | $641 |
| Meloxicam | 149 | $496 |
| Dexamethasone | 124 | $460 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $275 |
| Tramadol Hcl | 27 | $87 |
| ConstuloseLactulose | 13 | $65 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Temple
- Kirby HittTemple$9.1M
- Stephen BurkhartSan Antonio$185.3M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.